Terms: = Head and neck cancer AND ACVR2A, ACVR2, 92, ENSG00000121989, ACTRII, P27037 AND Treatment
2910 results:
1. Association between prognosis and lymph node status using
Ohsawa M; Hamai Y; Emi M; Ibuki Y; Kurokawa T; Yoshikawa T; Hirohata R; Kitasaki N; Okada M
World J Surg; 2024 Mar; 48(3):650-661. PubMed ID: 38686781
[TBL] [Abstract] [Full Text] [Related]
2. The clinical value of iodine-125 seed implantation in the treatment of iodine-refractory differentiated thyroid carcinoma.
Wan Q; Tan L; Tang X; Wang W; Su Y; Wu Z; Ke M; Chen Z
Front Endocrinol (Lausanne); 2024; 15():1327766. PubMed ID: 38686207
[TBL] [Abstract] [Full Text] [Related]
3. Assessment of Thyroid Carcinogenic Risk and Safety Profile of GLP1-RA Semaglutide (Ozempic) Therapy for Diabetes Mellitus and Obesity: A Systematic Literature Review.
Feier CVI; Vonica RC; Faur AM; Streinu DR; Muntean C
Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673931
[TBL] [Abstract] [Full Text] [Related]
4. Chylous leakage after esophagectomy for esophageal cancer: a systematic review.
Zheng X; Yang X; Lei S
J Cardiothorac Surg; 2024 Apr; 19(1):240. PubMed ID: 38632619
[TBL] [Abstract] [Full Text] [Related]
5. Platinum-based adjuvant chemoradiotherapy versus adjuvant radiotherapy in patients with head and neck adenoid cystic carcinoma.
Qiu Z; Wu Z; Zhou X; Lin M; Su Y; Tao Y
J Cancer Res Clin Oncol; 2024 Apr; 150(4):195. PubMed ID: 38625410
[TBL] [Abstract] [Full Text] [Related]
6. Survival analysis of Sudanese oral squamous cell carcinoma patients with field of cancerization.
Eltohami Y; Suleiman A
BMC Cancer; 2024 Apr; 24(1):473. PubMed ID: 38622532
[TBL] [Abstract] [Full Text] [Related]
7. [Phase Ⅱ clinical trial of PD-1 inhibitor combined with chemotherapy for locally advanced resectable oral squamous cell carcinoma].
Wang HL; Yue K; Wu YS; Duan YS; Jing C; Wang XD
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2024 Apr; 59(4):335-342. PubMed ID: 38599641
[No Abstract] [Full Text] [Related]
8. Pembrolizumab-based first-line treatment for PD-L1-positive, recurrent or metastatic head and neck squamous cell carcinoma: a retrospective analysis.
Cirillo A; Marinelli D; Romeo U; Messineo D; De Felice F; De Vincentiis M; Valentini V; Mezi S; Valentini F; Vivona L; Chiavassa A; Cerbelli B; Santini D; Bossi P; Polimeni A; Marchetti P; Botticelli A
BMC Cancer; 2024 Apr; 24(1):430. PubMed ID: 38589857
[TBL] [Abstract] [Full Text] [Related]
9. Characterization of parotid gland tumors using diffusion-relaxation correlation spectrum imaging: a preliminary study.
Chen W; Geng D; Xu XQ; Hu WT; Dai YM; Wu FY; Zhu LN
Clin Radiol; 2024 Jun; 79(6):e878-e884. PubMed ID: 38582630
[TBL] [Abstract] [Full Text] [Related]
10. Risk of recurrence after neoadjuvant chemotherapy and transoral robotic surgery in patients with oropharynx cancer that avoid adjuvant radiation.
Pershad AR; Thakkar PG; Goodman JF; Joshi A; Steinberg SM; Allen CT; Floudas CS
Cancer Med; 2024 Apr; 13(7):e7146. PubMed ID: 38581118
[TBL] [Abstract] [Full Text] [Related]
11. Outcomes of transoral robotic surgery for early-stage oropharyngeal squamous cell carcinoma with low rates of adjuvant therapy: A consecutive single-institution study from 2013 to 2020.
Meldgaard Justesen M; Kronberg Jakobsen K; Fenger Carlander AL; Hjordt Holm Larsen M; Wessel I; Kiss K; Friborg J; Ibrahim Channir H; Rubek N; Grønhøj C; von Buchwald C
Oral Oncol; 2024 May; 152():106783. PubMed ID: 38569317
[TBL] [Abstract] [Full Text] [Related]
12. Blood leukocytes as a non-invasive diagnostic tool for thyroid nodules: a prospective cohort study.
Wang F; Zhao D; Xu WY; Liu Y; Sun H; Lu S; Ji Y; Jiang J; Chen Y; He Q; Gong C; Liu R; Su Z; Dong Y; Yan Z; Liu L
BMC Med; 2024 Apr; 22(1):147. PubMed ID: 38561764
[TBL] [Abstract] [Full Text] [Related]
13. Pembrolizumab plus concurrent chemoradiotherapy versus placebo plus concurrent chemoradiotherapy in patients with locally advanced squamous cell carcinoma of the head and neck (KEYNOTE-412): a randomised, double-blind, phase 3 trial.
Machiels JP; Tao Y; Licitra L; Burtness B; Tahara M; Rischin D; Alves G; Lima IPF; Hughes BGM; Pointreau Y; Aksoy S; Laban S; Greil R; Burian M; Hetnał M; Delord JP; Mesía R; Taberna M; Waldron JN; Simon C; Grégoire V; Harrington KJ; Swaby RF; Zhang Y; Gumuscu B; Bidadi B; Siu LL;
Lancet Oncol; 2024 May; 25(5):572-587. PubMed ID: 38561010
[TBL] [Abstract] [Full Text] [Related]
14. Neoadjuvant therapy with chemotherapy and immune checkpoint inhibitor for laryngeal function preservation in locally advanced hypopharyngeal cancer.
Wu SG; Wang RJ; Zhou Y; Luo XY
Front Immunol; 2024; 15():1364799. PubMed ID: 38524124
[TBL] [Abstract] [Full Text] [Related]
15. Radiation Therapy Oncology Group 8502 "QUAD shot" regimen using volumetric modulated arc therapy for incurable head and neck cancer.
Toya R; Fukugawa Y; Saito T; Matsuyama T; Yoshida R; Murakami D; Orita Y; Nakayama H; Oya N
Oral Oncol; 2024 Apr; 151():106752. PubMed ID: 38518555
[TBL] [Abstract] [Full Text] [Related]
16. Neoadjuvant PD-1 Plus Chemotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma.
Qian T; Liu D; Cao G; Chen Z; Zhang Q
Technol Cancer Res Treat; 2024; 23():15330338241231610. PubMed ID: 38497137
[TBL] [Abstract] [Full Text] [Related]
17. Artificial Intelligence-Based Radiotherapy Contouring and Planning to Improve Global Access to cancer Care.
Court LE; Aggarwal A; Jhingran A; Naidoo K; Netherton T; Olanrewaju A; Peterson C; Parkes J; Simonds H; Trauernicht C; Zhang L; Beadle BM;
JCO Glob Oncol; 2024 Mar; 10():e2300376. PubMed ID: 38484191
[TBL] [Abstract] [Full Text] [Related]
18. Construction and validation of classification models for predicting the response to concurrent chemo-radiotherapy of patients with esophageal squamous cell carcinoma based on multi-omics data.
Li ZM; Liu W; Chen XL; Wu WZ; Xu XE; Chu MY; Yu SX; Li EM; Huang HC; Xu LY
Clin Res Hepatol Gastroenterol; 2024 Apr; 48(4):102318. PubMed ID: 38471582
[TBL] [Abstract] [Full Text] [Related]
19. Diagnostic Accuracy of JES Classification for Prediction of Invasion Depth in Superficial Esophageal Squamous Carcinoma: Meta-Analysis.
Fu D; Zhao H; Lan W; Li Y
J Coll Physicians Surg Pak; 2024 Mar; 34(3):336-342. PubMed ID: 38462871
[TBL] [Abstract] [Full Text] [Related]
20. Deletion of concurrent chemotherapy on the basis of sequential chemoradiotherapy for non-metastatic stage T4 nasopharyngeal carcinoma in IMRT era.
Zheng Y; Xue F; Ou D; Niu X; Hu C; He X
Cancer Med; 2024 Feb; 13(4):e6578. PubMed ID: 38457191
[TBL] [Abstract] [Full Text] [Related]
[Next]
